On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma about its approach to Acute Myeloid Leukemia, also known as AML. Then, Dr. Nik Sopko, the chief scientific officer of PolarityTE, talked about their design for wound healing. Their first treatment candidate is diabetic foot ulcers and Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.